All Work

Rich Duprey

Maybe I Wasn’t So Wrong About Reddit After All

Last November, I published an article admitting I got Reddit (NYSE:RDDT | RDDT Price Prediction) “epically wrong.” Since its March 2024 IPO, I had been skeptical about the company’s prospects, with my main concerns…

Rich Duprey · 8 months ago

Netflix Stock Tanks 39% — Is It Too Cheap to Ignore?

Netflix (NASDAQ:NFLX | NFLX Price Prediction) won the streaming wars that exploded after the pandemic, outlasting a surge of competitors to stand as the only major service delivering consistent profits. While rivals like Disney…

Rich Duprey · 8 months ago

FDA and HHS Hammer Hims & Hers In Compounded Drug Crackdown

Hims & Hers (NYSE:HIMS) shares are plunging 16% in after-hours trading following coordinated moves by two federal agencies against its compounded weight-loss drugs. The Food and Drug Administration (FDA) announced plans to restrict active…

Rich Duprey · 8 months ago

Is This the Market Crash Warren Buffett Was Waiting For?

Warren Buffett stepped down as CEO of Berkshire Hathaway (NYSE:BRK-A | BRK-A Price Prediction)(NYSE:BRK-B) at the end of 2025, ending a legendary career of more than 60 years that turned a failing textile company…

Rich Duprey · 8 months ago

Super Micro Computer Tumbles on AI Boom Backlash

Super Micro Computer (NASDAQ:SMCI | SMCI Price Prediction) reported robust artificial intelligence (AI) growth in its fiscal second-quarter results on Tuesday after the markets closed, with revenue surging 123% year-over-year to $12.7 billion, exceeding…

Rich Duprey · 8 months ago

Alphabet’s AI Spending Spree Is Fueling Broadcom’s Next Big Rally

Alphabet (NASDAQ:GOOG | GOOG Price Prediction)(NASDAQ:GOOGL) reported fourth-quarter earnings that exceeded analyst estimates, with full-year revenue exceeding $400 billion for the first time ever. However, the tech stock’s guidance for 2026 capital expenditures, ranging…

Rich Duprey · 8 months ago

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

The rivalry in the GLP-1 market between pharmaceutical leaders Eli Lilly (NYSE:LLY | LLY Price Prediction) and Novo Nordisk (NYSE:NVO) has intensified following their latest fourth-quarter earnings reports. Novo Nordisk initially dominated the space…

Rich Duprey · 8 months ago